Thymosin beta-4 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
The absence of salt in the seasoning is justified by the fact that the salt present in the butter at the time was sufficient. Lancelot de Casteau makes no comment on the vegetable, its origin, its price, or the ease or difficulty of finding it on the market. However, he has been using potatoes since at least December 12, 1557, since the dish "boiled potato" appears in the third course of the banquet that he organized on that date for the Joyous Entry of Prince-Bishop Robert of Berghes. As a court cook, he had to use quality products while keeping a reasonable budget, as he worked on his own funds and was only paid after presenting his statement of fees. The potato was cooked in the Principality of Liege sixty years before being offered "as a rarity at the table of the king" of France Louis XIII, in 1616.
The Aleutian Islands ( ə-LOO-shən or ə-LEW-shən), also called the Aleut Islands, or Aleutic Islands, are a chain of 14 main, larger volcanic islands and 55 smaller ones. Most of the islands belong to the U.S. state of Alaska, with the archipelago encompassing the Aleutians West Census Area and the Aleutians East Borough. The Commander Islands, located farther to the west, belong to the Russian federal subject of Kamchatka Krai, of the Russian Far East. The islands form part of the Aleutian Arc of the Northern Pacific Ocean, and occupy a land area of 6,821 sq mi (17,666 km2) that extends westward roughly 1,200 mi (1,900 km) from the Alaska Peninsula mainland, in the direction of the Kamchatka Peninsula; the archipelago acts as a border between the Bering Sea to the north and the Pacific Ocean to the south. Crossing longitude 180°, at which point east and west longitude end, the archipelago contains both the westernmost and easternmost parts of the United States, by longitude (Amatignak Island and Semisopochnoi Island, respectively). The westernmost U.S. island, in real terms, however, is Attu Island, west of which runs the International Date Line. The islands, with their 57 volcanoes, form the northernmost part of the Pacific Ring of Fire. Physiographically, they are a distinct section of the larger Pacific Border province, which, in turn, is part of the larger Pacific Mountain System physiographic division. The islands are considered to be among the most geographically isolated areas of the Northern Pacific.
However, this period of stability did not last. In 2013, Brady was caught attempting to poach deer. Instead of facing the consequences, he fled Vermont while still on furlough, violating the terms of his release. He eventually settled in North Carolina. In February of that year, Brady was pulled over for a seatbelt violation and responded by shooting State Trooper Michael Potts four times. The officer survived, but the attack led to Brady receiving a 24-year prison sentence at the Pasquotank Correctional Institution for state charges of attempted murder. Additionally, Brady was convicted of federal charges of felony possession of firearms for the same shooting incident, and he was sentenced to 40 years in federal prison by Chief United States District Judge William Lindsay Osteen Jr., although he remained in North Carolina serving his sentence for the state charges for which he was convicted.
=== Uses and importance to humans === Food crops Some aquatic plants are used by humans as a food source. Examples include wild rice (Zizania), water caltrop (Trapa natans), Chinese water chestnut (Eleocharis dulcis), Indian lotus (Nelumbo nucifera), water spinach (Ipomoea aquatica), prickly waterlily (Euryale ferox), and watercress (Rorippa nasturtium-aquaticum).
Sources: en.wikipedia.org
Saint-Simon was fascinated by the enormous potential of science and technology and advocated a socialist society that would eliminate the disorderly aspects of capitalism and would be based on equal opportunities. He advocated the creation of a society in which each person was ranked according to his or her capacities and rewarded according to his or her work. The key focus of Saint-Simon's socialism was on administrative efficiency and industrialism and a belief that science was the key to the progress of human civilisation. This was accompanied by a desire to implement a rationally organised economy based on planning and geared towards large-scale scientific progress and material progress, embodying a desire for a more directed or planned economy. The term "socialism" was first used in English in the British Cooperative Magazine in 1827 and came to be associated with the followers of Owen such as the Rochdale Pioneers, who founded the co-operative movement. Owen's followers stressed both participatory democracy and economic socialisation in the form of consumer co-operatives, credit unions, and mutual aid societies. In the case of the Owenites, they also overlapped with a number of other working-class and labour movements such as the Chartists in the United Kingdom.
Chief complaint (CC): the reason for the current medical visit. These are the symptoms. They are in the patient's own words and are recorded along with the duration of each one. Also called chief concern or presenting complaint. Current activity: occupation, hobbies, what the patient actually does professionally and non-professionally. Family history (FH): listing of diseases in the family that may impact the patient. A family tree is sometimes used. History of present illness (HPI): the chronological order of events of symptoms and further clarification of each symptom. Distinguishable from history of previous illness, often called past medical history (PMH). Medical history comprises HPI and PMH. Medications (Rx): what drugs the patient takes including prescribed, over-the-counter, and home remedies, as well as alternative and herbal medicines or remedies. Allergies are also recorded. Past medical history (PMH/PMHx): concurrent medical problems, past hospitalizations and operations, injuries, past infectious diseases or vaccinations, history of known allergies. Review of systems (ROS) or systems inquiry: a set of additional questions to ask, which may be missed on HPI: a general enquiry (have you noticed any weight loss, change in sleep quality, fevers, lumps and bumps? etc.), followed by questions on the body's main organ systems (heart, lungs, digestive tract, urinary tract, etc.). Social history (SH): birthplace, residences, marital history, social and economic status, habits (including diet, medications, tobacco, alcohol).
== Introduction == The two primary classes of therapeutics are small molecules and protein therapeutics. The design of small molecule inhibitors of protein-protein interactions (PPIs) has been impeded by issues such as the general lack of small-molecule starting points for drug design, the typical flatness of the interface, the difficulty of distinguishing real from artifactual binding, and the size and character of typical small-molecule libraries. Meanwhile, the protein therapeutics that lack these issues are bedeviled by another problem, poor cell penetration due to an insufficient ability to diffuse across the cell membrane. Additionally, proteins and peptides are often subject to proteolytic degradation in vivo or if they do enter the cell. Furthermore, small peptides (such as single alpha-helices or α-helices) can lose helicity in solution due to entropic factors, which diminishes binding affinity. α-Helices are the most common protein secondary structure and play a key role in mediating many PPIs by serving as recognition motifs. PPIs are frequently misregulated in disease, providing the long-running impetus to create alpha-helical peptides to inhibit disease-state PPIs for clinical applications, as well as for basic science applications. Introducing a synthetic brace (staple) helps to lock a peptide in a specific conformation, reducing conformational entropy. This approach can increase target affinity, increase cell penetration, and protect against proteolytic degradation.
The interaction between fibronectin and the integrin receptor causes a conformational change in the fibronectin. Additional receptors bind to fibronectin bringing in type I collagen, procollagen I and collagen V. These molecules interact with fibronectin to promote fibril formation on the surface of the cell.
== Technological achievements == In addition to being credited with the development of one of the first anti-virus programs, "Vaccine", Tippett pioneered and commercialized a string of now-common technologies including what is now called the "Recovery Disk," processor image signatures, using hash-tables for trusted file execution and anomaly detection, aspects of mail merge and "un-do." He ran a bulletin board system for CP/M software before the first IBM PC was created and was president of the Cleveland Osborne Group (a user group for the computers of the Osborne Computer Corporation) in the early 1980s. As chief scientist for ICSA.net, Tippett was one of a handful of experts to identify and address the ILOVEYOU virus that broke in May 2000 and provided key information to the Department of Justice about David Smith, the writer of the Melissa virus. He was featured on the cover of the August 2000 issue of Time Digital magazine.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.